Last week, the SEC prevailed in its first federal court trial of FY 2017. On November 14, 2016, the SEC announced that a jury in the U.S. District Court in the Northern District of California had found a doctor and his friend liable for insider trading in the case of SEC v. Sabrdaran et al.
